Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Managing Tough Real Life Dermatology Cases
Description
The presentation by Dr. Samantha Polly at Duke University discusses the management of two complex dermatology cases. The first case involves a 53-year-old male with a history of gout who presents with pustular lesions and is eventually diagnosed with Sweet's syndrome, characterized by neutrophilic dermatosis. His treatment included a prolonged Prednisone taper and dapsone, but issues of neutropenic fever and eventual necrotizing fasciitis led to hospitalization and surgical intervention. The case highlights the importance of monitoring for adverse effects of treatments, such as dapsone-induced agranulocytosis.
The second case features a 78-year-old female with a history of diabetes and renal disease presenting with hemorrhagic vesicles. Despite initial treatments for infections, her condition worsens, leading to confusion among her care team. An extensive diagnostic workup points toward iododerma, linked to recent exposure to contrast media and compounded by her renal status. Treatment focused on supportive care, and outcomes suggest that thorough patient history and interdisciplinary collaboration are vital in identifying rare dermatological conditions. Overall, the presentation emphasizes the necessity of a comprehensive approach to dermatology cases to avoid misdiagnosis and improve patient management.
Conclusions
- A 53-year-old male diagnosed with Sweet syndrome showed significant improvement with a combination of prednisone and dapsone despite an initial misdiagnosis during his hospital admissions.
- Dapsone-induced agranulocytosis was identified as a significant risk for severe complications, demonstrating the necessity for diligent monitoring and patient education regarding symptoms.
- In rare dermatological conditions like iododerma, multidisciplinary collaboration is essential to manage complex cases effectively, especially when multiple potential triggers are present.
- Cryptococcoid bodies on histology can indicate an underlying neutrophilic dermatosis, emphasizing the importance of detailed pathological examination for accurate diagnosis.
- Both cases highlight the critical need for thorough investigations to distinguish between overlapping clinical manifestations of dermatological syndromes.
- St Claire K, Kaul S, Caldito EG, Kramer ON, Griffin T, Albrecht J. Dapsone-induced agranulocytosis: symptoms may alert more reliably than the current blood monitoring protocol. Br J Dermatol. 2021 May;184(5):962-963. doi: 10.1111/bjd.19708.
- Hsieh CY, Tsai TF. Drug-Induced Neutropenia During Treatment of Non-Neoplastic Dermatologic Diseases: A Review. Clin Drug Investig. 2020 Oct;40(10):915-926. doi: 10.1007/s40261-020-00956-w.
- Sherban A, Fuller C, Sethi M, McGeehin E, Hirokawa D, Guerrieri C, Lee J, Yang S. Bullous hemorrhagic Sweet syndrome with cryptococcoid neutrophils in patients positive for antineutrophil cytoplasmic antibody without primary vasculitis. JAAD Case Rep. 2020 Oct 15;6(12):1196-1200. doi: 10.1016/j.jdcr.2020.10.006.
- Lim JH, Lee JS. Acute iododerma presenting as cryptococcoid neutrophilic dermatosis: A clinicopathological pitfall and interesting findings gleaned from a review of the literature. J Cutan Pathol. 2023 Jan;50(1):29-34. doi: 10.1111/cup.14310.
- Calvão J, Mira FS, Cardoso JC. Facial Vegetating Lesions in a Patient With Kidney Failure. JAMA Dermatol. 2021 Jun 1;157(6):725-726. doi: 10.1001/jamadermatol.2021.1104.
- Korman AM, Plaza JA, Kaffenberger BH. lododerma Simulating Cryptococcal Infection. Cutis. 2023 Oct;112(4):E7-E9. doi: 10.12788/cutis.0873.
- Runge M, Williams K, Scharnitz T, Nakamura M, Eshaq M, Mancuso J, Helfrich Y, Bresler SC, Andea A, Chan MP, Lowe L. lodine toxicity after iodinated contrast: New observations in iododerma. JAAD Case Rep. 2020 Mar 25;6(4):319-322. doi: 10.1016/j.jdcr.2020.02.006.
- Tasker F, Fleming H, McNeill G, Creamer D, Walsh S. Contrast media and cutaneous reactions. Part 2: Delayed hypersensitivity reactions to iodinated contrast media. Clin Exp Dermatol. 2019 Dec;44(8):844-860. doi: 10.1111/ced.13991.